Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,030.00
+320.00 (4.15%)
Apr 2, 2026, 2:20 PM KST
Market Cap760.70B +135.4%
Revenue (ttm)200.71B +25.4%
Net Income12.56B
EPS152.00
Shares Out98.66M
PE Ratio50.72
Forward PEn/a
Dividend125.00 (1.58%)
Ex-Dividend DateDec 29, 2025
Volume1,988,120
Average Volume4,957,231
Open7,870.00
Previous Close7,710.00
Day's Range7,530.00 - 8,170.00
52-Week Range3,200.00 - 9,890.00
Beta0.78
RSI58.79
Earnings DateMay 7, 2026

About Bukwang Pharmaceutical

Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication... [Read more]

Sector Healthcare
Founded 1960
Employees 615
Stock Exchange Korea Stock Exchange
Ticker Symbol 003000
Full Company Profile

Financial Performance

Financial Statements